絞り込み

16555

広告

Meningococcal B Vaccine Immunogenicity in Children With Defects in Complement and Splenic Function.

著者 Martinón-Torres F , Bernatowska E , Shcherbina A , Esposito S , Szenborn L , Marti MC , Hughes S , Faust SN , Gonzalez-Granado LI , Yu LM , D'Agostino D , Calabresi M , Toneatto D , Snape MD
Pediatrics.2018 Aug 01 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (8view , 0users)

Full Text Sources

The capsular group B meningococcal vaccine (4CMenB) is recommended for children with complement deficiencies, asplenia, and splenic dysfunction; however, data on the immunogenicity of 4CMenB in these "at-risk" children are missing.
PMID: 30068713 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード